Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study

BMC Endocrine Disorders

Table 2 Characteristics and metabolic markers in sarcopenic obese and non-sarcopenic obese women with polycystic ovary syndrome

	Non-Sarcopenic Obese	Sarcopenic Obese	Normal Clinical Range
BMI	27.1 (22.3–30.9)**	36.0 (30.4–39.7)
%ASM	26.3 (25.0–28.3)**	22.5 (21.0–23.0)
Waist Circumference (cm)	88.8 (78.8–100.4)**	108.9 (95.6–119.6)
hsCRP (mg • L⁻¹)	0.9 (0.4–4.5)**	5.1 (2.0–9.9)	0-7^a
HOMA	2.38 (0.67–3.44)*	3.55 (1.74–5.90)	< 2.73^b
Vitamin D (25-OH) (nmol • L⁻¹)	63.8 (42.9–99.5)*	49.6 (39.1–65.6)	25–70 (relative insufficient); 70–250 (optimal)^a
HbA1C (%)	5.1 (4.9–5.4)*	5.5 (5.2–5.6)	4.5–6.5^a

Data are presented as median (interquartile range). (*) represents significant difference between groups, p < 0.01; (**) represents significant difference between groups, p < 0.0001. %ASM, % appendicular skeletal muscle mass; BMI, body mass index; HbA1C, glycosylated hemoglobin; HOMA, homeostasis model assessment insulin resistance index hsCRP, high sensitive C-reactive protein
^aSaskatoon Health Region, Saskatoon, SK
^bCut off value for insulin resistance [20]

ISSN: 1472-6823